The company aims to conduct research and development activities in the field of drug discovery. The company may acquire, manage, and transfer patents, trademarks, and technical and industrial knowledge, acquire, manage, and dispose of real estate both domestically and abroad, invest in other companies both domestically and abroad, establish branches and subsidiaries both domestically and abroad. The company may participate in group financing, particularly by granting loans to its direct or indirect shareholders or other group companies or providing guarantees or other securities of any kind for their liabilities to third parties, even if such loans or securities are in the sole interest of its direct or indirect shareholders or other group companies and are granted free of charge. The company may engage in all other transactions that directly or indirectly promote the aforementioned purposes.